Skip to main content
ACR Convergence 2024 Main banner
Final Program


Schedule at a Glance
Legend
Presentation Icons
In Person
In Person
On Demand
On Demand
Live Stream
Live Stream

  1. Home

  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    Antiphospholipid Syndrome Poster
    Antiphospholipid Syndrome
     CME 0 hours
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0098: Anti-HSP90α as a Protective Natural Antibody Against Secondary Antiphospholipid Syndrome in Systemic Lupus Erythematosus
    Abstract Poster Presenter: Marina Barguil Macedo, MD, MS (she/her/hers) – University of Washington
    Antiphospholipid Syndrome
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0099: Modulating Pentose Phosphate Pathway Metabolism to Temper Neutrophil Hyperactivity in Antiphospholipid Syndrome
    Abstract Poster Presenter: Kaitlyn Sabb, BS – University of Michigan - Ann Arbor
    Antiphospholipid Syndrome
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0100: Association Between the Active Form of Plasminogen Activator Inhibitor 1 (PAI-1) and Endothelial Cell Activation in Antiphospholipid Syndrome
    Abstract Poster Presenter: Yuzhou Gan, BS – University of Michigan
    Antiphospholipid Syndrome
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0101: Metabolomic Profiling Reveals a Role for Citric Acid Cycle Dysfunction in Antiphospholipid Syndrome Neutrophils
    Abstract Poster Presenter: Ajay Tambralli, MD – University of Michigan
    Antiphospholipid Syndrome
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0102: Single-cell Profiling of Dermal Endothelial Cells Identifies Unique Molecular Pathways Associated with Small-Vessel Events and Nephropathy in Antiphospholipid Syndrome
    Abstract Poster Presenter: Wenying Liang, PhD, MBBS – University of Michigan
    Antiphospholipid Syndrome
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0103: CD10highLow-Density Granulocytes Is a Potential Marker of Disease Activity in Antiphospholipid Syndrome
    Abstract Poster Presenter: Chun Li, MD (she/her/hers) – Peking University People's Hospital
    Antiphospholipid Syndrome
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0104: Proteomic Analysis Identifies Neutrophil Defensin 1 as a Biological Marker for Antiphospholipid Syndrome
    Abstract Poster Presenter: Yuebing Wang, BA – Peking University
    Antiphospholipid Syndrome
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0105: Novel Autoantibodies Identified in the Antiphospholipid Syndrome
    Abstract Poster Presenter: Shikai Hu, n/a – Peking Union Medical College Hospital
    Antiphospholipid Syndrome
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0106: IgM and IgG Phosphatidylserine Antibody Detection May Improve Classification Accuracy of SLE and APS
    Abstract Poster Presenter: Christina Donath, MD – SUNY Upstate University Hospital, Department of Medicine, Rheumatology Fellowship Program
    Antiphospholipid Syndrome
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0107: Screening for Non-criteria Antiphospholipid Autoantibodies in Patients Younger Than 50 Years Old Admitted for Venous Thromboembolism: A Cross-sectional Study
    Abstract Poster Presenter: Yachar DAWUDI, n/a (he/him/his) – Assistance Publique Hôpitaux de Paris
    Antiphospholipid Syndrome
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0108: Phenotypic Characterization of Patients with IgM Antibodies in Antiphospholipid Syndrome (APS)
    Abstract Poster Presenter: Fernanda Lopes, MD – Rheumatology Division, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil
    Antiphospholipid Syndrome
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0109: Natural History and Clinical Implications of Lupus Autoantibodies in Primary Antiphospholipid Antibody Positive Patients: Results from the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository (“Registry”)
    Abstract Poster Presenter: Rohan Willis, MBBS;DM;MSc – University of Texas Medical Branch
    Antiphospholipid Syndrome
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0110: Binding Characteristics of Patient Clusters Among Anticardiolipin and Anti-β2-Glycoprotein I ELISA and Non-ELISA Assays: A Survey by the Association of Medical Laboratory Immunologists
    Abstract Poster Presenter: Rohan Willis, MBBS, DM, MSc – University of Texas Medical Branch
    Antiphospholipid Syndrome
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0111: Comparative Performance of ELISA and CLIA Against the 2023 ACR/EULAR APS Classification Criteria
    Abstract Poster Presenter: Polona Zigon, PhD – Department of Rheumatology, University Medical Centre Ljubljana
    Antiphospholipid Syndrome
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0112: Efforts to Harmonize ELISA and Non-ELISA Anticardiolipin and Anti-β2-glycoprotein-I Levels Based on ISTH SSC LA/aPL and APS ACTION International Multicenter Cohorts
    Abstract Poster Presenter: Arne Vandevelde, PharmD, MSc – Ghent University
    Antiphospholipid Syndrome
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0113: Plasma Proteomics Analysis Identifies Thromboinflammatory Signature Associated with Clinical Antiphospholipid Syndrome: Results from Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) Registry
    Abstract Poster Presenter: Alexander Pine, MD, PhD – Yale School of Medicine/VA Connecticut
    Antiphospholipid Syndrome
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0114: Rare Germline Variants in Complement Regulatory Genes in Antiphospholipid Antibody Positive Patients: Prospective Results from AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository (“Registry”)
    Abstract Poster Presenter: Cecile Yelnik, PhD – lille university
    Antiphospholipid Syndrome
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0115: Regional and Ethnoracial Differences Among Antiphospholipid Antibody-Positive Patients with No Other Systemic Autoimmune Rheumatic Diseases: Results from AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Registry
    Abstract Poster Presenter: Elena Gkrouzman, MD,MS,RhMSUS – University of Massachusetts
    Antiphospholipid Syndrome
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0116: Assessment of Triple Antiphospholipid Antibody-positive Patients Based on Clinical and Laboratory Domains of 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria
    Abstract Poster Presenter: Reyhan Kose Cobanoglu, MD – Aydin Adnan Menderes University School of Medicine
    Antiphospholipid Syndrome
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0117: Validation of the 2023 American College of Rheumatology/European League Against Rheumatism Antiphospholipid Syndrome Classification Criteria in the Pediatric Population
    Abstract Poster Presenter: Daniel Bar, MD (he/him/his) – Edmond and Lilly Safra Children's Hospital, Sheba Medical Center
    Antiphospholipid Syndrome
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0118: Performance of the 2023 ACR/EULAR Classification Criteria for Antiphospholipid Syndrome in a Mexican Cohort
    Abstract Poster Presenter: Erik Cimé-Aké, MSc – Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán
    Antiphospholipid Syndrome
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0119: Clinical and Serological Distinctions and Evolutionary Predictors in Antiphospholipid Syndrome and Systemic Lupus Erythematosus: A Multicenter Cohort Analysis
    Abstract Poster Presenter: Basant Elnady, MD, FRCP – Benha University, Egypt . Al Hada Armed Hospital, KSA
    Antiphospholipid Syndrome
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0120: Vascular Liver Disorders in Patients with Antiphospholipid Syndrome: A Retrospective National Multicentre Study
    Abstract Poster Presenter: Mathilde Katims, -None- (she/her/hers) – Université Paris Cité
    Antiphospholipid Syndrome
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0121: Intra-renal Involvement in Primary Antiphospholipid Antibodies Syndrome: Data from Two Italian Centers
    Abstract Poster Presenter: Liala Moschetti, MD (she/her/hers) – Rheumatology Unit ASST Spedali Civili and University of Brescia
    Antiphospholipid Syndrome
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0122: Association of Cognitive Impairment Measured by Montreal Cognitive Assessment and Plasma Levels of Growth Differentiation Factor 15 in Patients with Antiphospholipid Antibody Syndrome
    Abstract Poster Presenter: Evelyn Aranda Cano, DM – Departament of rheumatology Instituto Nacional de Cardiología Ignacio Chávez
    Antiphospholipid Syndrome
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0123: The Impact of Sedentary Behavior and Physical Activity Level on Clinical Parameters and Quality of Life in Patients with Primary Antiphospholipid Syndrome (PAPS)
    Abstract Poster Presenter: Danieli Andrade, MD,PhD – University of Sao Paulo
    Antiphospholipid Syndrome
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0124: Sexual Health Challenges in Primary Antiphospholipid Syndrome: Exploring Prevalence and Clinical Correlates
    Abstract Poster Presenter: Jonathan Campos-Guzmán, MD – UNAM - INCMNSZ
    Antiphospholipid Syndrome
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0125: Electronic Health Record Rule-Based Computable Phenotype of Antiphospholipid Syndrome
    Abstract Poster Presenter: Emily Balczewski, BA – University of Michigan
    Antiphospholipid Syndrome
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0126: Underdiagnosis Prediction Fingerprint for Antiphospholipid Syndrome Derived from Electronic Health Record Data
    Abstract Poster Presenter: Emily Balczewski, BA – University of Michigan
    Antiphospholipid Syndrome
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0127: Unsupervised Machine Learning Improves Clinical Stratification and Prognostic Evaluation for Antiphospholipid Syndrome: A Large Cohort Study from China
    Abstract Poster Presenter: Chen Chen, MD – Peking University People's Hospital
    Antiphospholipid Syndrome
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0128: Damage Index in Patients with Thrombotic Antiphospholipid Syndrome (DIAPS) Version 2.0: One Single Center Pilot Study
    Abstract Poster Presenter: Laura Aline Martinez-Martinez, PhD – Rheumatology Department National Institute of Cardiology Ignacio Chávez
    Antiphospholipid Syndrome
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0129: The Efficacy and Safety of Telitacicept Following Rituximab Immunotherapy on Antiphospholipid Syndrome, a Prospective 24- Week Study
    Abstract Poster Presenter: Guillermo Pons-Estel, n/a – Centro Regional de Enfermedades Autoinmunes y Reumáticas (GO-CREAR), Rosario, Argentina
    Antiphospholipid Syndrome
  • Saturday, Nov 16th
    3:00 PM – 4:30 PM Eastern Time
    16S59: Abstracts: Antiphospholipid Syndrome
    Location: Room 103AB
    Abstract Moderator: Felipe Andrade, MD,PhD – The Johns Hopkins University School of Medicine
    Abstract Moderator: Ali Duarte-Garcia, MD, MSc – Mayo Clinic
    Antiphospholipid Syndrome
     CME 0 hours
  • Saturday, Nov 16th
    3:00 PM – 3:15 PM Eastern Time
    0837: Bispecific Autoantigen-T Cell Engagers (BaiTE) to Selectively Target Autoreactive B Cells in Antiphospholipid Syndrome
    Location: Room 103AB
    Presenting Author: Maximilian F. Konig, MD – The Johns Hopkins University School of Medicine
    Antiphospholipid Syndrome
  • Saturday, Nov 16th
    3:15 PM – 3:30 PM Eastern Time
    0838: The Mechanistic Impact of IgA anti-beta-2 Glycoprotein I on Accelerated Atherosclerosis in Primary APS
    Location: Room 103AB
    Presenting Author: Kavya Sugur, PhD, MSc (she/her/hers) – Division of Rheumatology, Department of Internal Medicine, University of Michigan, Ann Arbor
    Antiphospholipid Syndrome
  • Saturday, Nov 16th
    3:30 PM – 3:45 PM Eastern Time
    0839: Comprehensive Single-cell Analysis Reveals Interferon Pathway Activation and Aberrant B Cell Dynamics in APS Autoimmunity
    Location: Room 103AB
    Presenting Author: Haoyu Pan, PhD candidate – Department of Rheumatology and lmmunology, Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China
    Antiphospholipid Syndrome
  • Saturday, Nov 16th
    3:45 PM – 4:00 PM Eastern Time
    0840: The Platelet Adenosinergic Axis as a Novel Therapeutic Target for Thrombotic APS
    Location: Room 103AB
    Presenting Author: NaveenKumar Somanathapura, PhD – University of Michigan
    Antiphospholipid Syndrome
  • Saturday, Nov 16th
    4:00 PM – 4:15 PM Eastern Time
    0841: Clinical and Biologic Predictors of Thrombosis in Persistently Antiphospholipid Antibody Positive Patients: Prospective Analysis of the International APS ACTION Clinical Database and Repository (“Registry”)
    Location: Room 103AB
    Presenting Author: Jonathan Thaler, MD (he/him/his) – Hospital for Special Surgery
    Antiphospholipid Syndrome
  • Saturday, Nov 16th
    4:15 PM – 4:30 PM Eastern Time
    0842: The Incident Risk and Predictors of Systemic Autoimmune Rheumatic Disease (SARD) Development in Persistently Antiphospholipid Antibody Positive Patients Without SARDs: Prospective Results from the APS ACTION Clinical Database and Repository (“Registry”)
    Location: Room 103AB
    Presenting Author: Reyhan Kose Cobanoglu, MD – Aydin Adnan Menderes University School of Medicine
    Antiphospholipid Syndrome